CME Responsibilities and Requirements  

Accreditation Statement

The ºÃÉ«ÏÈÉú of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ºÃÉ«ÏÈÉú of Medicine designates this live activity for a maximum of up to 1.5 AMA PRA Category 1 credit (s) â„¢. Physicians should only claim credit commensurate with the extent to their participation in the activity.

Objectives

At the conclusion of this activity, participants should be able to:

  1. Identify the most recent changes in the ASCCP Colposcopy guidelines.
  2. Discuss current immunotherapy in gynecologic cancers.
  3. Identify future areas of study toward a paradigm of precision medicine in gynecologic oncology.

Disclosure Statement

ºÃÉ«ÏÈÉú of Medicine (MSM) in accordance with ACCME guidelines requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MSM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and the appropriateness of patient care recommendations. Full disclosure of speaker relationships will be made at this activity.

Resolution of Conflict of Interest

In accordance with the ACCME Standards for Commercial Support of CME, the Morehouse School of Medicine has implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Disclaimer Statement

This information provided at this CME activity is for continuing education purposes and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

CE QR Code

 Coming soon!